Governance GSK plc

Azioni

GSK

GB00BN7SWP63

Prodotti farmaceutici

Mercato chiuso - London S.E. 17:35:06 24/06/2025 Variaz. 5gg Var. 1 gen.
1.410,00 GBX +0,50% Grafico intraday di GSK plc -4,73% +4,72%

Comitato esecutivo: GSK plc

Manager
Posizioni ricoperteDa
Emma Walmsley

Emma Walmsley

56 anni

Chief Executive Officer 01/04/2017
Julie Brown

Julie Brown

63 anni

Director of Finance/CFO 01/05/2023
Graham Rivers

Graham Rivers

Comptroller/Controller/Auditor 01/01/1998
Timothy Woodthorpe

Timothy Woodthorpe

Treasurer 01/01/2000
Shobie Ramakrishnan

Shobie Ramakrishnan

Chief Tech/Sci/R&D Officer 01/12/2021
Mick Readey

Mick Readey

Investor Relations Contact 01/03/2021
Victoria Whyte

Victoria Whyte

Corporate Secretary 27/01/2009
Diana Conrad

Diana Conrad

Human Resources Officer 01/01/2016
James Ford

James Ford

Compliance Officer 01/08/2018
General Counsel 01/08/2018
Tony Wood

Tony Wood

Chief Tech/Sci/R&D Officer 19/01/2022

Composizione del Consiglio di amministrazione: GSK plc

Amministratore
ComitatiDa
Jonathan Symonds

Jonathan Symonds

67 anni

Governance Committee Chair 01/09/2019
Nominating Committee Chair 01/09/2019
Wendy Becker

Wendy Becker

59 anni

Nominating Committee 01/10/2023
Governance Committee Chair
Compensation Committee
Compensation Committee Chair 01/10/2023
Audit Committee 01/10/2023
Governance Committee 01/10/2023
Elizabeth Anderson

Elizabeth Anderson

67 anni

Compensation Committee Chair
Governance Committee Chair
Nominating Committee Chair
Governance Committee 10/07/2019
Audit Committee 01/09/2022
Compensation Committee 01/09/2022
Charles Bancroft

Charles Bancroft

65 anni

Compensation Committee 18/07/2022
Governance Committee 06/05/2021
Nominating Committee 06/05/2021
Audit Committee Chair 13/03/2021
Anne Beal

Anne Beal

63 anni

Compensation Committee 01/09/2024
Governance Committee 18/07/2022
Nominating Committee 18/07/2022
Harry Dietz

Harry Dietz

67 anni

Governance Committee 11/03/2024
Nominating Committee 11/03/2024
Emma Walmsley

Emma Walmsley

56 anni

Compensation Committee 04/12/2019
Julie Brown

Julie Brown

63 anni

Audit Committee Chair 05/08/2024
Gavin Screaton

Gavin Screaton

Director/Board Member 01/05/2025
Jeannie Lee

Jeannie Lee

Director/Board Member 04/03/2024
Vishal Sikka

Vishal Sikka

58 anni

Director/Board Member 18/07/2022
Independent Dir/Board Member 18/07/2022
Hal Barron

Hal Barron

63 anni

Director/Board Member 01/01/2018

Ex dirigenti e amministratori: GSK plc

Insider
Posizioni ricoperte
DaA
Roy Anderson
Roy Anderson
Director/Board Member 01/10/2007 03/05/2018
Independent Dir/Board Member 18/04/2011 03/05/2018
Andrew Witty
Andrew Witty
Director/Board Member 31/01/2008 31/03/2017
Chief Executive Officer 21/05/2008 31/03/2017
Corporate Officer/Principal 01/01/2003 21/05/2008
Moncef Slaoui
Moncef Slaoui
Director/Board Member 13/10/2009 31/03/2017
Chief Tech/Sci/R&D Officer 01/06/2006 22/10/2014
Corporate Officer/Principal 22/10/2014 31/03/2017
Daniel Podolsky
Daniel Podolsky
Director/Board Member 01/07/2006 05/05/2016
Independent Dir/Board Member 18/04/2011 05/05/2016
Deryck Charles Maughan
Deryck Charles Maughan
Director/Board Member 01/07/2004 05/05/2016
Independent Dir/Board Member 18/04/2011 05/05/2016
Stephanie Burns
Stephanie Burns
Director/Board Member 12/02/2007 05/05/2016
Independent Dir/Board Member 18/04/2011 05/05/2016
Tom de Swaan
Tom de Swaan
Director/Board Member 01/01/2006 08/05/2015
Independent Dir/Board Member 10/02/2011 08/05/2015
Christopher Gent
Christopher Gent
Chairman 01/06/2004 01/03/2015
Independent Dir/Board Member 01/06/2004 01/03/2015
Robert Wilson
Robert Wilson
Director/Board Member 01/11/2003 07/05/2014
Independent Dir/Board Member 18/04/2011 07/05/2014
Crispin Davis
Crispin Davis
Director/Board Member 01/07/2003 01/01/2013
Independent Dir/Board Member 18/04/2011 01/01/2013
Eddie J. Gray
Eddie J. Gray
Corporate Officer/Principal 01/01/2001 01/01/2013
Larry Culp
Larry Culp
Director/Board Member 01/07/2003 30/09/2012
Independent Dir/Board Member 18/04/2011 30/09/2012
Julian Heslop
Julian Heslop
Director/Board Member 13/10/2009 13/10/2009
Director of Finance/CFO 01/04/2005 31/03/2011
Russell Greig
Russell Greig
Corporate Officer/Principal 01/04/2003 01/04/2010
Ronaldo Hermann Schmitz
Ronaldo Hermann Schmitz
Director/Board Member 23/05/2000 20/05/2009
Ian Maurice Gray Prosser
Ian Maurice Gray Prosser
Director/Board Member 23/05/2000 01/05/2009
Independent Dir/Board Member 23/05/2000 20/05/2009
Michael D. Rogers
Michael D. Rogers
Corporate Officer/Principal 01/01/2001 01/01/2007
M. Berrey
M. Berrey
Corporate Officer/Principal 01/01/2004 01/01/2007
Jennie Younger
Jennie Younger
Public Communications Contact 01/12/2001 01/06/2006
Lucy Shapiro
Lucy Shapiro
Director/Board Member 01/01/2001 17/05/2006
Peter J. Job
Peter J. Job
Director/Board Member - 31/12/2004
Christopher Hogg
Christopher Hogg
Director/Board Member - 31/12/2004
John Hector McArthur
John Hector McArthur
Director/Board Member - 17/05/2004
Michèle Barzach
Michèle Barzach
Director/Board Member 01/01/1997 17/05/2004
Independent Dir/Board Member 01/01/1997 17/05/2004
Donald F. McHenry
Donald F. McHenry
Director/Board Member - 17/05/2004
Paul A. Allaire
Paul A. Allaire
Director/Board Member - 05/06/2003
F. Roger Hurn
F. Roger Hurn
Director/Board Member - 05/06/2003
James R. Beery
James R. Beery
General Counsel 01/12/2000 01/06/2001
Charles Bramlage
Charles Bramlage
Corporate Officer/Principal 01/01/1983 01/04/2001
Rupert Bondy
Rupert Bondy
General Counsel 01/01/2001 -
Ford Calhoun
Ford Calhoun
Chief Tech/Sci/R&D Officer 01/01/2001 -
Christopher Chipman
Christopher Chipman
Corporate Officer/Principal 01/08/1998 01/03/2000
Tamar Howson
Tamar Howson
Corporate Officer/Principal 01/01/1991 01/01/2000
Anthony S. Murabito
Anthony S. Murabito
Chief Tech/Sci/R&D Officer 01/01/1981 01/01/2000
Ursula B. Bartels
Ursula B. Bartels
Corporate Officer/Principal 01/01/1988 01/01/1999
Elaine Jones
Elaine Jones
Corporate Officer/Principal - 31/12/1998
Geoffrey Nichol
Geoffrey Nichol
Corporate Officer/Principal 01/12/1989 01/01/1996
Leon Palandjian
Leon Palandjian
Corporate Officer/Principal 01/01/1991 31/12/1994
Paul W. Hawran
Paul W. Hawran
Treasurer 01/07/1984 01/05/1993
Albert W. Gianchetti
Albert W. Gianchetti
Corporate Officer/Principal - -
Jim Weiss
Jim Weiss
Corporate Officer/Principal - -
Jamie Oakes
Jamie Oakes
Corporate Officer/Principal - -
David Searls
David Searls
Corporate Officer/Principal - -
Irene Hrusovsky
Irene Hrusovsky
Chief Tech/Sci/R&D Officer - -
Colin W. Dykes
Colin W. Dykes
Corporate Officer/Principal - -
Martin N. Mercer
Martin N. Mercer
Corporate Officer/Principal - -
Janet Hammond
Janet Hammond
Corporate Officer/Principal - -
Victor Paulus
Victor Paulus
General Counsel - -
Barry Brand
Barry Brand
Corporate Officer/Principal - -
Olivier Jean Bohuon
Olivier Jean Bohuon
Corporate Officer/Principal - -
John H. Dillon
John H. Dillon
Corporate Officer/Principal - -
Chris Diener
Chris Diener
Corporate Officer/Principal - -
Susan M. Welsh
Susan M. Welsh
Corporate Officer/Principal - -
L. William McIntosh
L. William McIntosh
Corporate Officer/Principal - -
Heather Giles
Heather Giles
Corporate Officer/Principal - -
Marshall Hayward
Marshall Hayward
Director/Board Member - -
Paul A. Litka
Paul A. Litka
Corporate Officer/Principal - -
Anthony P. Hurley
Anthony P. Hurley
Corporate Officer/Principal - -
Ben Nelson
Ben Nelson
Corporate Officer/Principal - -
David Pulman
David Pulman
Corporate Officer/Principal 01/01/2001 -
John A. Young
John A. Young
Director/Board Member - -
Simon M. Bicknell
Simon M. Bicknell
Corporate Officer/Principal 11/02/2011 -
Luigi Xerri
Luigi Xerri
Corporate Officer/Principal - -
John W. Morgan
John W. Morgan
General Counsel - -
Donnie Hardison
Donnie Hardison
Sales & Marketing - -
Robert Bedford
Robert Bedford
Corporate Officer/Principal - -
Frank Cattie
Frank Cattie
Corporate Officer/Principal - -
Gitte Neubauer
Gitte Neubauer
Corporate Officer/Principal - -
Thomas M. Rossi
Thomas M. Rossi
Corporate Officer/Principal - -
Gwendolyn Powell Painter
Gwendolyn Powell Painter
Chief Tech/Sci/R&D Officer - -
Eduardo Bravo Fernández de Araoz
Eduardo Bravo Fernández de Araoz
Corporate Officer/Principal - -
Pieter Muntendam
Pieter Muntendam
Corporate Officer/Principal - -
Michel G. Lurquin
Michel G. Lurquin
Director/Board Member - -
Chief Tech/Sci/R&D Officer - -
William John Edward Burt
William John Edward Burt
Corporate Officer/Principal - -
Paul Nicholson
Paul Nicholson
Corporate Officer/Principal - -
Akiyoshi Uchiyama
Akiyoshi Uchiyama
Chief Tech/Sci/R&D Officer - -
Barry S. Butler
Barry S. Butler
Corporate Officer/Principal - -
James E. Goldschmidt
James E. Goldschmidt
Corporate Officer/Principal - -
Thomas P. Blackburn
Thomas P. Blackburn
Director/Board Member - -
John Easter
John Easter
Corporate Officer/Principal - -
Jeffrey Sardis
Jeffrey Sardis
Corporate Officer/Principal - -
Jeffrey Walsh
Jeffrey Walsh
Corporate Officer/Principal - -
Michael J. Capaldi
Michael J. Capaldi
Corporate Officer/Principal - -

Distribuzione dell'età dei dirigenti

Parità di genere

Uomo20
Donna13

Di cui Comitato esecutivo

Uomo5
Donna5

Di cui Direttori

Uomo8
Donna4

Revisioni

Revisione fatturato 1 anno
-
Revisione fatturato 4 mesi
-
Revisione fatturato 1 mesi
-
Revisione EPS 1 anno
-
Revisione EPS 4 mesi
-
ESG MSCI
AA

ESG

Ambiente
Sociale
Governance
Controversie
Controversie etiche
-
Controversie sui diritti umani
-
Controversie sussidi fiscali
-
In linea con la finanza islamica
-
Logo GSK plc
GSK plc è un'azienda biofarmaceutica globale. I segmenti dell'azienda comprendono le Operazioni Commerciali e la Ricerca e Sviluppo. Sviluppa farmaci antitumorali per i pazienti, tra cui il cancro ovarico, il cancro endometriale e il mieloma multiplo. Le sue aree di prodotto comprendono i vaccini, i farmaci speciali e la medicina generale. Si concentra anche sulla risposta alle esigenze di trattamento non soddisfatte dei pazienti con patologie respiratorie e infiammatorie. Il suo portafoglio di vaccini comprende oltre 20 vaccini che aiutano a proteggere le persone da una serie di malattie e infezioni, tra cui meningite, herpes zoster e influenza. I suoi farmaci speciali sono impegnati anche nello sviluppo di farmaci per le malattie respiratorie e l'HIV. I suoi farmaci generici comprendono farmaci inalatori per l'asma e la broncopneumopatia cronica ostruttiva, antibiotici e farmaci per le malattie della pelle. L'azienda sta avanzando i farmaci oligonucleotidici nell'epatite cronica B e nella malattia epatica steatotica, nonché in altre aree terapeutiche oltre a quella epatica.
Dipendenti
68.629
Altre informazioni sulla società

Partenze di persone chiave

Richard Sykes
-
Richard Sykes

Chief Executive Officer

01/01/1995 01/01/2002

Jean-Pierre Garnier
-
Jean-Pierre Garnier

Chief Executive Officer

23/05/2000 21/05/2008

Christopher Gent
-
Christopher Gent

Chairman

01/06/2004 01/03/2015

Andrew Witty
-
Andrew Witty

Chief Executive Officer

21/05/2008 31/03/2017

Philip Hampton
-
Philip Hampton

Chairman

07/05/2015 01/09/2019